Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terlipressin Versus Somatostatin/Octreotide on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage (TORCH): A Retrospective Multicenter Observational Study

NCT03846180 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.

NCT NCT03846180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03846180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terlipressin Versus Somatostatin/Octreotide on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage (TORCH): A Retrospective Multicenter Observational Study
Lead sponsor
General Hospital of Shenyang Military Region
Phase
Observational
Overall status
Completed
Start date
March 1, 2019
Completion date
July 1, 2019
Enrollment
1,682 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, kidney injury, variceal hemorrhage